Mass Vaccine and Drug Administration, Bangladesh

This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass vaccinations, combined mass vaccinations and drug administrations versus the current standard of care.

NCT Number	NCT06068530
Lead Sponsor	University of Oxford
Conditions	Plasmodium Falciparum Malaria
Enrollment	10,000 participants
Start Date	2025-02-15
Primary Completion	2028-02-01 (estimated)
Study Completion	2028-02-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-18